Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Crossover Pragmatic Study to Evaluate Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Patients With Spinal Muscular Atrophy. REALITY Study.

NCT05354414 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT05354414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Crossover Pragmatic Study to Evaluate Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Patients With Spinal Muscular Atrophy. REALITY Study.
Lead sponsor
Biogen
Phase
Not applicable
Overall status
Completed
Start date
May 11, 2022
Completion date
July 12, 2024
Enrollment
63 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

spinal muscular atrophy (sma)